Advisor Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Advisor Group’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-21,242	Closed	-$381K	–	5209
2017 Q4	$381K	Buy	21,242 +767	+4%	+$9.44K	0.01%	1510
2017 Q3	$242K	Buy	20,475 +6,361	+45%	+$71.4K	﹤0.01%	1711
2017 Q2	$148K	Buy	14,114 +6,210	+79%	+$63.3K	﹤0.01%	2006
2017 Q1	$87K	Buy	7,904 +1,704	+27%	+$19.8K	﹤0.01%	2272
2016 Q4	$84K	Buy	6,200 +4,897	+376%	+$68.3K	﹤0.01%	2203
2016 Q3	$16K	Sell	1,303 -597	-31%	-$7.04K	﹤0.01%	3316
2016 Q2	$19K	Buy	+1,900	New	+$21.3K	﹤0.01%	3113

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Advisor Group's SCMP Position: Q1 2018 in Review

Advisor Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 21,242 shares — an estimated $381K sold.

Advisor Group first reported a position in SCMP in Q2 2016 and held it in 7 quarters. The position peaked at $381K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Advisor Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Advisor Group sold 21,242 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $381K.
Advisor Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2016 and held it in 7 quarters.
Advisor Group's Sucampo Pharmaceuticals, Inc. position peaked at $381K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Advisor Group's 13F filing for Q1 2018, filed 15 May 2018.